Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merck & Co Inc (NYSE:MRK)

62.70
Delayed Data
As of 3:59pm ET
 +0.20 / +0.32%
Today’s Change
58.29
Today|||52-Week Range
66.80
+6.51%
Year-to-Date

Today’s Trading

Previous close62.50
Today’s open62.43
Day’s range62.34 - 62.93
Volume401,830
Average volume (3 months)8,661,350
Market cap$170.5B
Dividend yield3.00%
Data as of 3:59pm ET, 08/16/2017

Growth & Valuation

Earnings growth (last year)-9.62%
Earnings growth (this year)+2.29%
Earnings growth (next 5 years)+7.20%
Revenue growth (last year)+1.86%
P/E ratio33.8
Price/Sales4.15
Price/Book4.29

Competitors

 Today’s
change
Today’s
% change
NVSNovartis+0.28+0.33%
PFEPfizer-0.02-0.06%
SNYSanofi+0.62+1.30%
ABBVAbbVie+0.09+0.13%
Data as of 3:59pm ET, 08/16/2017

Financials

Next reporting dateOctober 27, 2017
EPS forecast (this quarter)$1.03
Annual revenue (last year)$39.5B
Annual profit (last year)$3.9B
Net profit margin9.93%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
Kenneth C. Frazier
CFO &
Executive Vice President-Global Services
Robert M. Davis
Corporate headquarters
Kenilworth, New Jersey

Forecasts